Humoral immune response after COVID-19 vaccination.

Humoral immune response after COVID-19 vaccination. - HINCI-Bremen

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025567

Enrollment

Registered

2021-06-16

Start date

2021-06-13

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1

Interventions

Group 1: SARS-Cov-2 serology with determination of spike and nucleocapsid antibodies.

Eligibility

Sex/Gender

All

Age

18 Years to 68 Years

Inclusion criteria

Inclusion criteria: Condition after Corona vaccination. At least 2 weeks after the end of the vaccination series and not more than 3 months after the last vaccination.

Exclusion criteria

Exclusion criteria: End of vaccination series not earlier than 14 days to not longer than 3 months ago.

Design outcomes

Primary

Measure	Time frame
Achievement of a necessary number of study participants. Once the laboratory results of these individuals are available, primary conclusions can be made about the humoral immune response after COVID-19 vaccination.	—

Secondary

Measure	Time frame
Secondarily, a control of the antibody titers is planned approx. 6 months after the first examination in order to be able to make statements about the course.	—

Countries

Germany

Contacts

Public ContactJan Neumann

Performa NordZentrum für Gesunde ArbeitArbeitsmedizinischer Dienst

jan.neumann@performanord.bremen.de0421-361-6743

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026